SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

30 Jan 2026 Evaluate
The Sales for the quarter ended December 2025 of Rs. 95.74 millions rose by 38.53% from Rs. 69.11 millions.Net Profit for the quarter ended December 2025 zoomed to 233.45% from Rs. 2.84 millions to Rs. 9.47  millions.Operating profit for the quarter ended December 2025 rose to 14.28 millions as compared to 5.58 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 95.74 69.11 38.53 262.23 254.00 3.24 324.92 279.29 16.34
Other Income 5.56 1.05 429.52 16.75 4.98 236.35 10.24 1.76 481.82
PBIDT 14.28 5.58 155.91 37.87 16.93 123.69 27.33 17.88 52.85
Interest 0.37 0.24 54.17 1.25 0.89 40.45 1.27 1.42 -10.56
PBDT 13.91 5.34 160.49 36.62 16.04 128.30 29.47 16.46 79.04
Depreciation 1.48 1.54 -3.90 4.44 4.82 -7.88 6.29 6.62 -4.98
PBT 12.43 3.80 227.11 32.18 11.22 186.81 23.18 9.84 135.57
TAX 2.96 0.96 208.33 7.61 2.83 168.90 5.77 2.32 148.71
Deferred Tax 0.22 0.30 -26.67 0.60 0.85 -29.41 1.23 1.34 -8.21
PAT 9.47 2.84 233.45 24.57 8.39 192.85 17.41 7.52 131.52
Equity 137.21 128.73 6.59 137.63 128.73 6.91 137.63 128.73 6.91
PBIDTM(%) 14.92 8.07 84.73 14.44 6.67 116.66 8.41 6.40 31.39

Eiko Lifesciences Share Price

53.50 1.18 (2.26%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3611.60
Tata Chemicals 690.25
SRF 2471.15
Pidilite Inds. 1360.30
Deepak Nitrite 1465.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×